Fig. 1From: Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trialsThe pooled risk ratio of overall thromboembolism between the SARS-CoV-2 vaccine and the placebo groupsBack to article page